PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportspsoriasis
MeSH D011565 - psoriasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D017444:Papulosquamous skin diseases
$
Success rate
D011565: 
Psoriasis
D015535:Psoriatic arthritis
D000098650:Guttate psoriasis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAcitretin Acitretin  2013-04-04   
Betamethasone Betamethasone  1987-08-10   
Calcitriol Calcitriol  2001-10-12   
Cortisone Cortisone  1982-01-01   
Cyclosporine Cyclosporine  2005-03-25   
Mycophenolate mofetil Mycophenolate Mofetil  2009-05-04   
Mycophenolate mofetil Mycophenolate mofetil Teva  2008-02-21   
Mycophenolate mofetil Myfenax  2008-02-21   
Novast LaboratoriesBetamethasone Betamethasone  2017-05-24   
PadagisBetamethasone Betamethasone  1990-01-31   
Betamethasone, Calcipotriene Calcipotriene Betamethasone  2014-12-12   
Betamethasone, Calcipotriene Calcipotriene Bethamethasone  2020-09-11   
Cyclosporine Cyclosporine  2003-10-07   
Fluocinolone acetonide Fluocinolone  2013-08-09   
Tazarotene Tazarotene  2023-04-25   
Taro PharmaceuticalBetamethasone Betamethasone  1985-05-14   
Betamethasone, Calcipotriene Calcipotriene Betamethasone  2020-09-02   
Clotrimazole, Betamethasone Clotrimazole Betamethasone  2001-05-29   
Betamethasone Dermabet  1988-01-06   
Fluocinolone acetonide Fluocinolone  1994-10-31   
Tazarotene Tazarotene  2017-04-03   
Glenmark PharmaceuticalsBetamethasone Betamethasone  2008-09-23   
Calcipotriene Calcipotriene  2010-03-24   
Clotrimazole, Betamethasone Clotrimazole Betamethasone  2015-10-30   
Fluocinolone acetonide Flucinolone  2018-10-25   
Fluocinolone acetonide Fluocinonide  2018-10-26   
Betamethasone, Calcipotriene Calcipotriene Betamethasone  2023-03-21   
LEO PharmaCalcipotriene Dovonex  1993-12-29   
Betamethasone, Calcipotriene Enstilar 2031-06-10 2015-10-16   
Brodalumab Kyntheum  2017-07-17   
Betamethasone, Calcipotriene Taclonex  2006-01-09   
MylanAcitretin Acitretin  2015-09-10   
Cyclosporine Cyclosporine  2022-02-02   
Betamethasone Luxiq  1999-02-28   
Mycophenolate mofetil Mycophenolate Mofetil  2009-05-04   
Methotrexate Methotrexate  1992-05-15   
Mayne GroupTazarotene Fabior 2030-02-24 2012-05-11   
Calcipotriene Sorilux 2026-05-26 2010-10-06   
Johnson & JohnsonInfliximab Remicade  1999-08-13 $1,556 M Q2/24-Q1/25 
Ustekinumab Stelara  2009-01-15 $9,535 M Q2/24-Q1/25 
Guselkumab Tremfya  2017-07-13 $3,817 M Q2/24-Q1/25 
PerrigoBetamethasone Betamethasone  1986-06-10   
Fluocinolone acetonide Fluocinolone  1982-03-04   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
56%
49/87
Phase 2
46%
49/107
Phase 3
76%
69/91
Approved: 37Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use